Literature DB >> 15322813

Pulmonary abscess due to leflunomide use in rheumatoid arthritis: a case report.

H Ulusoy1, A Bilgici, O Kuru, C Celenk.   

Abstract

A 43-year-old woman had rheumatoid arthritis (RA) for 5 years and complained of fever, arthralgia/myalgia, and night sweating for a month. She had been receiving only leflunomide (20 mg/day) for 5 months. On admission, there was no evidence of active arthritis or vasculitic lesion. Laboratory evaluation showed an erythrocyte sedimentation rate of 145 mm/h and C-reactive protein of 160 mg/dl. All cultures were negative. Chest radiograph and computed tomography (CT) revealed a pulmonary abscess. Staphylococcus aureus multiplied in the culture of a purulent sample obtained from the abscess under ultrasonography. The leflunomide was stopped, and sultamicillin (IV 4x2 g/day) was started for a further 6 weeks. Four weeks later, the patient had completely recovered and CT showed significant improvement of the pulmonary abscess. Ten milligrams/day of prednisolone and 7.5 mg/week of methotrexate were started for RA treatment. The patient has been under control for 5 months without any further abscess or RA activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322813     DOI: 10.1007/s00296-004-0493-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner.

Authors:  L C Hamilton; I Vojnovic; T D Warner
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Anaerobic Infections of the Lung.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

3.  Leflunomide induced vasculitis--a dose-response relationship.

Authors:  A T Y Chan; A Bradlow; J McNally
Journal:  Rheumatology (Oxford)       Date:  2003-03       Impact factor: 7.580

4.  Corticosteroids in IgA nephropathy: a randomised controlled trial.

Authors:  C Pozzi; P G Bolasco; G B Fogazzi; S Andrulli; P Altieri; C Ponticelli; F Locatelli
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

5.  Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.

Authors:  D L Scott; J S Smolen; J R Kalden; L B van de Putte; A Larsen; T K Kvien; M Schattenkirchner; P Nash; C Oed; I Loew-Friedrich
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

Review 6.  Mechanism of action for leflunomide in rheumatoid arthritis.

Authors:  R I Fox; M L Herrmann; C G Frangou; G M Wahl; R E Morris; V Strand; B J Kirschbaum
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

7.  Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors.

Authors:  L D Fairbanks; M Bofill; K Ruckemann; H A Simmonds
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

8.  Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

Authors:  J S Smolen; J R Kalden; D L Scott; B Rozman; T K Kvien; A Larsen; I Loew-Friedrich; C Oed; R Rosenburg
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

9.  Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis.

Authors:  M Cutolo; A Sulli; P Ghiorzo; C Pizzorni; C Craviotto; B Villaggio
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

10.  Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study.

Authors:  V Mladenovic; Z Domljan; B Rozman; I Jajic; D Mihajlovic; J Dordevic; M Popovic; M Dimitrijevic; M Zivkovic; G Campion
Journal:  Arthritis Rheum       Date:  1995-11
View more
  4 in total

1.  Suppressed wound healing in a patient with rheumatoid arthritis taking leflunomide (arava).

Authors:  D Miller Wise
Journal:  Perm J       Date:  2011

2.  Spontaneous multiple insufficiency fractures after pelvic abscess and sepsis in a rheumatoid arthritis patient treated with high-load corticosteroid therapy: a case report.

Authors:  Takeshi Mochizuki; Shigeki Momohara; Katsunori Ikari; Kouichiro Kawamura; So Tsukahara; Takuji Iwamoto; Shu Kobayashi; Hiroshi Okamoto; Kazumasa Nishimoto; Taisuke Tomatsu
Journal:  Clin Rheumatol       Date:  2007-01-18       Impact factor: 2.980

3.  Intrapulmonary rheumatoid nodules in a patient with long-standing rheumatoid arthritis treated with leflunomide.

Authors:  Ildiko Fanny Horvath; Antonia Szanto; Zoltan Csiki; Peter Szodoray; Margit Zeher
Journal:  Pathol Oncol Res       Date:  2008-04-08       Impact factor: 3.201

Review 4.  Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis.

Authors:  Peter Bb Jones; Douglas Hn White
Journal:  Open Access Rheumatol       Date:  2010-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.